Fish Oil Supplement in Rectal Cancer

Status Completed

Clinical Trial Summary

Neoadjuvant treatment with radiotherapy (RDT) and chemotherapy (CT) are the treatment of choice for rectal adenocarcinomas in stages II and III. This results currently in pathologic complete response in 10% to 30% of cases. The immune and inflammatory response is altered in these individuals and is directly related to response to therapy. Both the disease and the treatment of colorectal cancer have an impact on quality of life and nutritional status. In studies with cells and animal models the incorporation of fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) - derived from fish oil - has been shown to interfere in the process of inflammation, cell signaling and gene transcription enhancing the response to treatment. Are reported ability to restore the apoptosis of tumor cells, sensitization of tumor cells to chemotherapy, production of less pro-inflammatory cytokines and the preservation of normal energy and protein metabolism. The aim of this study is to verify if the daily consumption of 2.4 g EPA + DHA for adults in neoadjuvant therapy can promote changes on inflammatory and immunological markers of host response to tumor and if this response is altered by nutritional status. It is expected that supplementation can reflect in control of inflammatory and immune response in favor of tumor cell death contributes to pathological complete response and that it happens with preservation of nutritional status. Subjects will be randomized as to supplementation. All will be assessed in four moments during neoadjuvant therapy and immediate postoperative. Results will be presented by comparing the intervention group and control group at each moment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Rectal Neoplasms

Clinical Trial Details

NCT number	NCT02534389
Study type	Interventional
Source	AC Camargo Cancer Center
Contact
Status	Completed
Phase	N/A
Start date	January 2015
Completion date	February 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02537340` - PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR
Recruiting	`NCT02565667` - A Prospective Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL Stapler	N/A
Terminated	`NCT02538913` - Exercise Training for Rectal Cancer Patients	N/A
Not yet recruiting	`NCT02439086` - Prediction of Response to Neoadjuvant Therapy in Rectal Cancer	N/A
Completed	`NCT02233374` - Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET	N/A
Completed	`NCT00535041` - Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Recruiting	`NCT04949646` - Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision	N/A
Recruiting	`NCT04095468` - Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
Recruiting	`NCT06017583` - Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer	Phase 3
Recruiting	`NCT05689775` - Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
Recruiting	`NCT04006951` - Development of a Clinical and Biological Database in Rectum Cancer	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03714490` - MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer	Phase 2
Recruiting	`NCT03325361` - The Role of Transanal Tube Drainage as A Mean of Prevention of Anastomotic Leakage Anastomotic Leakage	N/A
Completed	`NCT02252250` - Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer	N/A
Completed	`NCT04455737` - Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT01721785` - Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer	N/A
Active, not recruiting	`NCT01171300` - Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients	N/A